Background Bone mineral density (BMD) is a putative marker for lifetime exposure to estrogen. Studies that have explored whether BMD is a determinant of mammographic density (MD) have observed inconsistent results. Therefore, we examined this potential association in a sample of women (n = 1,516) from the clinical sub-cohort in the Mexican teachers' cohort (n = 115,315). Methods We used multivariable linear regression to assess the association between quartiles of BMD and percent MD, as well as total dense and non-dense area of the breast, stratified by menopausal status. We also examined the associations by body mass index (BMI) (\30 kg/m 2 , C30 kg/m 2 ). Results Overall, there was no association between BMD and MD among premenopausal women. However, when we stratified by BMI, there was a modest inverse association between BMD and percent MD (difference between extreme quartiles = -2.8, 95 % CI -5.9, 0.27, p trend = 0.04) among women with BMI \ 30 kg/m 2 , but a positive association among obese women (comparable difference = 5.1, 95 % CI 0.02, 10.1, p trend = 0.03; p interaction \ 0.01). Among postmenopausal women, BMD and percent MD were positively associated after adjustment for BMI (p trend \ 0.01). Postmenopausal women in the highest two quartiles of BMD had 4-5 % point higher percent MD compared to women in the lowest quartile. The association did not differ by BMI in postmenopausal women (p interaction = 0.76). Conclusion Among obese premenopausal women as well as postmenopausal women, BMD was positively associated with percent MD. Among leaner premenopausal women, BMD and percent MD were modestly inversely associated. These findings support the hypothesis that cumulative exposure to estrogen (as measured by BMD) may influence MD.
Introduction
Mammographic density (MD) is one of the strongest predictors of breast cancer risk [1] . Women with high breast density ([75 %) have four to six times the risk of breast cancer compared to those with very low breast density [2] [3] [4] [5] . Hormone levels, including estrogen, are suspected to be a determinant of MD [6] [7] [8] . Bone mineral density (BMD) is regarded as a marker for lifetime exposure to estrogen [7] [8] [9] [10] and higher BMD has been linked with increased risk of breast cancer in some [11] [12] [13] [14] [15] [16] [17] , but not all studies [9, 18] . While MD is responsive to hormonal interventions, including hormone therapy (HT) and tamoxifen [19] , evidence for an association between cumulative lifetime exposure to estrogen, as measured by BMD, and MD is mixed [9, 14, [20] [21] [22] [23] [24] [25] . Further, no prior study has examined this association in Mexican women, a population that has increasing breast cancer incidence and mortality rates and may have unique risk factors [26] . Therefore, we examined the cross-sectional association between BMD and MD in a large sample of pre-and postmenopausal Mexican women.
Methods

Study population
The Mexican teachers' cohort (MTC or ESMaestras) is a prospective cohort study that was established in [2006] [2007] [2008] and includes 115,315 female public school teachers in Mexico. Details on the cohort have been described elsewhere [27] [28] [29] . The present analysis was based on a clinical sub-cohort of 2,084 MTC participants from the states of Jalisco and Veracruz who underwent mammography, anthropometry measurements, and an interview in 2007. Within this clinical sub-cohort, 1,707 women underwent a mammogram, of whom 1,679 also had their BMD measured. We excluded women with missing data on menopausal status (n = 81), participants with a prior breast cancer diagnosis (n = 11), missing data on body mass index (BMI) (n = 6), and users of HT who reported they were currently using HT on the 2006 baseline questionnaire (n = 65). Thus, the final analytic sample comprised 1,516 women (964 premenopausal and 552 postmenopausal).
Bone mineral density
Bone mineral density (BMD) was determined in the nondominant forearm with a PIXI dual-energy X-ray absorptiometry densitometer (Lunar Corp., Madison, WI) following the recommendations of the International Society for Clinical Densitometry and is measured as grams per centimeter squared (g/cm 2 ) [30] . All measurements took place within a mobile medical unit by trained personnel, and a bone specialist (A. Tamayo-Orozco) reviewed results. A prior study in younger Mexican women observed a correlation between BMD in the distal forearm with BMD as measured in the lumbar spine of 0.78 (95 % CI 0.73, 0.83) [31] .
Mammographic density
Using the Hologic Lorad M-III (Hologic, Bedford, MA, USA) in Veracruz and the Giotto Image M (Internazionale Medico Scientifica, Bologna, Italy) in Jalisco, a radiology technician carried out mammography on study subjects. The Agfa CP1000 developer (Agfa-Gevaert Group, Belgium) was used to develop mammograms, and an Astra 2400S scanner (Umax, Fremont, CA) was used to digitize the mammograms. A single observer measured total area and total dense area of the craniocaudal view of the left breast using Mamgr, a computer-assisted program developed at the Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine [32] [33] [34] . Density was assessed only for the left breast as prior studies have demonstrated that breast density of the left and right breast is highly correlated [35] . We calculated percent density by dividing total dense area by the total area of the breast; non-dense area was calculated by subtracting total dense area from the total area. The Mamgr observer was blinded to participant characteristics including BMD.
Covariate data
We obtained information on covariates [age at mammogram, family history of breast cancer, history of benign breast disease (BBD), metabolic equivalent of task (METs) per week, age at menarche, smoking, alcohol, parity, age at first birth, daily calcium intake, and past HT use] from the 2006 self-reported questionnaire. Weight and standing height measurements were taken using an electronic digital scale (Tanita Corp, Japan) to the nearest 0.1 kg and a wall stadiometer (Seca Corp., Hanover, MD) to the nearest millimeter. These measurements were used to calculate BMI (kg/m 2 ) for each individual. For 91 women with missing measured height or weight, BMI was calculated based on self-reported height and weight.
Statistical analyses
We categorized participants according to menopausal status-specific BMD quartiles. Multivariable linear regression was used to estimate the association between quartiles of BMD and percent MD, as well as with natural log-transformed dense area and natural log-transformed non-dense area. We adjusted for age, state of residence, family history of breast cancer, history of BBD, current BMI, METs per week, age at menarche, smoking, alcohol use, parity, age at first birth, calcium intake, and past HT use (among C30) . In sensitivity analyses, we restricted to never users of HT among postmenopausal women and stratified by state of residence (Jalisco, Veracruz). Analyses were completed using SAS (SAS version 9.3; SAS Institute; Cary, NC) and p values \0.05 were considered statistically significant.
Results
Mean age was 43 years (SD ± 4.1) among premenopausal women and 54 years (SD ± 5.3) among postmenopausal women. Mean BMD was 0.45 g/cm 2 (SD ± 0.06) and 0.40 g/cm2 (SD ± 0.06) among pre-and postmenopausal women, respectively. Mean percent MD was 37 % (SD ± 14.6) among premenopausal women and 28 % (SD ± 13.4) in postmenopausal women. As previously reported, percent mammographic density was higher among women in Jalisco compared to women in Veracruz [28] . Table 1 presents the distribution of characteristics by quartiles of BMD in pre-and postmenopausal women. Overall, women with higher BMD had greater BMI and higher levels of physical activity, while among postmenopausal women those with high BMD were also younger.
Overall, there was no association between BMD and percent MD in premenopausal women (difference between extreme quartiles = -0.21 % points; 95 % CI -2.8, 2.4; p trend = 0.73) (Table 2), nor was there an association between BMD and dense area (p trend = 0.68) or non-dense area (p trend = 0.40), after adjusting for BMI and other predictors of MD. However, the association between BMD and measures of MD did vary by BMI in premenopausal women. Among women whose BMI was \30 kg/m 2 , there was a modest inverse association between BMD and percent MD. Those in the highest quartile of BMD had 2.8 % point lower percent MD than those in the lowest BMD quartile (95 % CI -5.9, 0.27; p trend = 0.04) ( Table 3 ). In contrast, BMD was positively associated with percent MD among obese premenopausal women (BMI C 30 kg/m 2 ). Obese premenopausal women in the highest quartile of BMD had 5.1 % points greater percent MD than those in the lowest quartile (95 % CI 0.02, 10.1; p trend = 0.03; p interaction \ 0.01). Further, BMD was inversely associated with dense area among women whose BMI was \30 kg/m 2 (p trend \ 0.01), but suggestively positively associated in obese women (p trend = 0.09).
Among postmenopausal women, BMD was positively associated with percent MD (Table 2) . Women in the highest two quartiles of BMD had 4-5 % point greater percent MD than those in the lowest quartile (p trend \ 0.01). BMD was suggestively positively associated with dense area (p trend = 0.05) and inversely associated with non-dense area (p trend \ 0.01). There was no evidence for effect measure modification for the association between BMD and measures of MD by BMI among postmenopausal women (p interaction C 0.16) ( Table 3) .
Results were similar, though slightly attenuated, for percent MD among postmenopausal women when we restricted to never users of HT (difference between extreme quartiles = 3.3; 95 % CI -0.72, 7.3; p trend = 0.03) and did not differ by state of residence for either premenopausal (p interaction = 0.24) or postmenopausal women (p interaction = 0.52). Number of individuals with missing values: physical activity (n = 9), age at menarche (n = 26), smoking (n = 185), alcohol (n = 137), parity (n = 72), age at first birth among parous (n = 18), breastfeeding (n = 26), calcium intake (n = 10), indigenous language (n = 20), hormonal contraceptive use (n = 66), HT use (n = 20)
* Among parous women 
Discussion
In this population of Mexican women, there was no overall association between BMD and percent MD in premenopausal women. After stratification by BMI, we observed a significant positive association between BMD and percent MD among obese (BMI C 30) premenopausal women. Among postmenopausal women, BMD was positively associated with percent MD and dense breast area and inversely associated with non-dense area of the breast. Given that BMD is considered a marker of cumulative estrogen exposure [6] [7] [8] and some studies suggested positive associations between BMD and breast cancer risk [10, 11, 13, 36] , researchers initially hypothesized that BMD may also be positively correlated with mammographic density [9, 20] . However, no associations were found in these or the majority of subsequent studies [9, 20, [22] [23] [24] [25] , though some reported inverse associations [14] [15] [16] [17] [18] [19] [20] . Thus, our results contradict the majority of published literature to date. Our findings of positive associations between BMD and MD in postmenopausal women do agree with one published cross-sectional study, however, which reported a 4-5 % point difference in MD among women in the top quartile of BMD compared to those in the bottom quartile [21] , effect sizes remarkably consistent with our findings. In addition, Sung et al. [24] reported a positive association among premenopausal, but not postmenopausal women.
Few prior studies considered possible differences in associations of BMD with MD by BMI. One study reported no difference by BMI, while in another study of postmenopausal women, a modest inverse association was observed among lean women (BMI \ 25 kg/m 2 ), but not among women with BMI C 25 kg/m 2 [20] . Our findings of significant effect modification by BMI among premenopausal women should be interpreted with caution given the small sample sizes in stratified analyses.
One potential reason for the inconsistency in results in the published literature to date may be HT use in study populations. Several prior studies considered current versus past or ever use of HT [9] , while others were able to stratify more finely (e.g., recent past use vs. Never use) [14, [20] [21] [22] 24] . Some authors did not mention adjustment for HT use [23, 25] . Given residual effects of HT use on breast density, the various considerations of HT use across previous analyses may contribute to divergent results. While it has been argued that recent exogenous hormone use may obscure an association between BMD and MD [21] , in the current analysis, we observed that significant positive associations in postmenopausal women persisted after adjustment for HT use and also after excluding ever users of HT.
Our analysis has some limitations. The use of BMD measured at the forearm in this study as opposed to the lumbar spine may have resulted in non-differential measurement error of BMD, potentially biasing our results toward the null. As this study is cross-sectional, we were unable to assess changes in bone and breast density over time. Strengths of this study include the standardized measurement of BMD and MD as well as the standardized collection of predictors of both breast and bone density and ability to adjust for potential confounding by these factors.
In conclusion, we observed that BMD and percent MD were positively associated in postmenopausal women as well as in obese premenopausal women in our sample of Mexican women and modestly inversely associated in leaner premenopausal women. These findings should reopen discussion of the possibility of a common cumulative estrogen-related pathway linking bone mineral density and breast density that may contribute to breast cancer risk. Further research in this area should include particular emphasis on understanding how and why the association may differ by BMI.
